MetLife Investment Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $765K | Hold |
|
|||||
|
2025
Q2 | $466K | Hold |
|
|||||
|
2025
Q1 | $611K | Sell |
|
|||||
|
2024
Q4 | $668K | Buy |
|
|||||
|
2024
Q3 | $915K | Hold |
|
|||||
|
2024
Q2 | $976K | Buy |
|
|||||
|
2024
Q1 | $960K | Buy |
|
|||||
|
2023
Q4 | $751K | Hold |
|
|||||
|
2023
Q3 | $505K | Hold |
|
|||||
|
2023
Q2 | $727K | Buy |
|
|||||
|
2023
Q1 | $668K | Buy |
|
|||||
|
2022
Q4 | $711K | Buy |
|
|||||
|
2022
Q3 | $650K | Hold |
|
|||||
|
2022
Q2 | $520K | Hold |
|
|||||
|
2022
Q1 | $470K | Buy |
|
|||||
|
2021
Q4 | $373K | Hold |
|
|||||
|
2021
Q3 | $326K | Hold |
|
|||||
|
2021
Q2 | $293K | Buy |
|
|||||
|
2021
Q1 | $251K | Hold |
|
|||||
|
2020
Q4 | $249K | Hold |
|
|||||
|
2020
Q3 | $166K | Hold |
|
|||||
|
2020
Q2 | $166K | Hold |
|
|||||
|
2020
Q1 | $123K | Buy |
|